Article
Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake
2024-07-21
Abstract excerpt
<h4>Context</h4> The gut microbiome has been shown to be in a bidirectional interaction with type 2 diabetes medications that have been in clinical use for several decades. However, the bidirectional effects of novel type 2 diabetes drugs semaglutide, empagliflozin, and the gut microbiome have yet to be clearly described. <h4>Objective</h4> We investigate the effect of semaglutide and empagliflozin initiation on t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f2316cfa-76be-525a-abc4-44908ce6e179
- DOI
- 10.1101/2024.07.19.24310611
